Kraig Biocraft Laboratories, Inc. Research And Development Expense

• Kraig Biocraft Laboratories, Inc. showed an increase of +0.8% in Research And Development Expense from 2024 to 2025.
• This data is from Kraig Biocraft Laboratories, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2017: $25.4 thousand | Q1 2018: $20.1 thousand | Q2 2018: $50.9 thousand | Q3 2018: $20.2 thousand | Q1 2019: $22.3 thousand | Q2 2019: $20.9 thousand | Q3 2019: $44.0 thousand | Q1 2020: $4.8 thousand | Q2 2020: $33.0 thousand | Q3 2020: $27.6 thousand | Q1 2021: $87.8 thousand | Q2 2021: $44.7 thousand | Q3 2021: $39.3 thousand | Q1 2022: $27.5 thousand | Q2 2022: $49.9 thousand | Q3 2022: $62.1 thousand | Q1 2023: $69.1 thousand | Q2 2023: $57.0 thousand | Q3 2023: $39.1 thousand | Q1 2024: $29.4 thousand | Q2 2024: $49.4 thousand | Q3 2024: $25.0 thousand | Q1 2025: $23.9 thousand | Q2 2025: $63.9 thousand | Q3 2025: $9.2 thousand.
• Over the full 16 years of available data (2010 to 2025), Kraig Biocraft Laboratories, Inc.'s Research And Development Expense has grown by 17.3%.
• Historical annual values: Fiscal year 2025: $165.8 thousand | Fiscal year 2024: $164.4 thousand | Fiscal year 2023: $237.9 thousand | Fiscal year 2022: $176.4 thousand | Fiscal year 2021: $197.7 thousand | Fiscal year 2020: $88.5 thousand | Fiscal year 2019: $223.1 thousand | Fiscal year 2018: $148.1 thousand | Fiscal year 2017: $258.9 thousand | Fiscal year 2016: $397.1 thousand | Fiscal year 2015: $432.0 thousand | Fiscal year 2014: $439.5 thousand | Fiscal year 2013: $489.4 thousand | Fiscal year 2012: $465.3 thousand | Fiscal year 2011: $250.6 thousand | Fiscal year 2010: $141.3 thousand.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026